- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/54 - BenzoxazolesHydrogenated benzoxazoles
Patent holdings for IPC class C07D 263/54
Total number of patents in this class: 97
10-year publication summary
8
|
5
|
8
|
2
|
5
|
3
|
4
|
8
|
3
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Alkermes, Inc. | 139 |
4 |
Vectus Biosystems Limited | 35 |
4 |
NRG Therapeutics Ltd | 13 |
4 |
Merck Sharp & Dohme Corp. | 2190 |
3 |
Semiconductor Energy Laboratory Co., Ltd. | 11487 |
3 |
Takeda Pharmaceutical Company Limited | 2704 |
3 |
Hoffmann-La Roche Inc. | 3489 |
2 |
Boehringer Ingelheim International GmbH | 4644 |
2 |
Syngenta Crop Protection AG | 6195 |
2 |
Bayer Cropscience AG | 2007 |
2 |
Sumitomo Chemical Company, Limited | 9092 |
2 |
Actelion Pharmaceuticals Ltd | 527 |
2 |
Aldeyra Therapeutics, Inc. | 103 |
2 |
J-pharma Co., Ltd. | 26 |
2 |
Nippon Chemiphar Co., Ltd. | 232 |
2 |
Sunshine Lake Pharma Co., Ltd. | 599 |
2 |
University of Houston System | 1095 |
2 |
Dethree Res. Lab. Inc. | 3 |
2 |
Bristol-myers Squibb Company | 4840 |
1 |
Samsung Display Co., Ltd. | 35545 |
1 |
Other owners | 50 |